Combined statin/coenzyme Q10 as adjunctive treatment of chronic heart failure

Medical Hypotheses

Volumn 73, Issue 3, 2009, Pages 306-308

  Okello, Emmy ^a   Jiang, Xuejun ^a   Mohamed, Salim ^a   Zhao, Qinyan ^a   Wang, Tao ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ATORVASTATIN; C REACTIVE PROTEIN; INTERLEUKIN 6; MALONALDEHYDE; MEVINOLIN; NITRIC OXIDE; PENTOXIFYLLINE; PRAVASTATIN; SIMVASTATIN; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; UBIDECARENONE;

ADJUVANT THERAPY; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CHOLESTEROL SYNTHESIS; CLINICAL TRIAL; DRUG POTENTIATION; ENERGY METABOLISM; FUNCTIONAL STATUS; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; LENGTH OF STAY; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PLEIOTROPY; PRIORITY JOURNAL; QUALITY OF LIFE;

CHEMOTHERAPY, ADJUVANT; CHRONIC DISEASE; DRUG THERAPY, COMBINATION; HEART FAILURE; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MODELS, CARDIOVASCULAR; UBIQUINONE;

EID: 67649647413     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2009.03.027     Document Type: Article

References (9)

1. Sola S., Mir M.Q., Lerakis S., Tandon N., and Khan B.V. Atorvastatin improves left ventricular systolic function and serum markers of inflammation in non ischemic heart failure. J Am Coll Cardiol 47 (2006) 332-337
2. Belardinelli R., Tiano L., and Littarru G.P. Oxidative stress, endothelial function and coenzyme Q10. Biofactors 32 1-4 (2008) 129-133
3. Pablo F.C., Rodrigo M., Hugo E.V., et al. Pleiotropic effects of atorvastatin in heart failure: role in oxidative stress, inflammation, endothelial function and exercise capacity. J Heart Lung Transplant 4-27 (2008) 435-441
4. Sliwa K., Angela W., Veuvette N.K., et al. Therapy of ischemic cardiomyopathy with immunomodulating agent pentoxifylline. Circulation 109 (2004) 750-755
5. Sliwa K., Olaf F., Elena L., et al. Peripartum cardiomyopathy: inflammatory markers as predictors of outcome in 100 prospectively studied patients. Eur Heart J 27 4 (2006) 441-446
6. Molyneux S.L., Florkowski C.M., George P.M., et al. Coenzyme Q10: an independent predictor of mortality in chronic heart failure. J Am Coll Cardiol 52 18 (2008) 1435-1441
7. Bargossi A.M., Grossi G., Fiorella P.L., Gaddi A., Di Giulio R., and Battino M. Exogenous CoQ10 supplementation prevents plasma ubiquinone reduction induced by HMG-CoA reductase inhibitors. Mol Aspects Med 15 Suppl. (1994) s187-s193
8. Ghirlanda G., Oradei A., Manto A., Lippa S., Uccioli L., Caputo S., et al. Evidence of plasma CoQ10-lowering effect by HMG-CoA reductase inhibitors: a double-blind, placebo-controlled study. J Clin Pharmacol 33 (1993) 226-229
9. Bleske B.E., Willis R.A., Anthony M., Casselberry N., Datwani M., Uhley V.E., et al. Effect of pravastatin and atorvastatin on coenzyme Q10. Am Heart J 142 2 (2001) E2